Clinical Trial Update: Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intravesical gemcitabine instillation after transurethral resection for low-risk superficial bladder cancer; the study status is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Superficial Bladder Cancer | Phase 2 | Status: COMPLETED